Health Affairs
The nearly $5 trillion US health care system has become an unlikely lifeline for Silicon Valley’s most expensive bet. As technology giants pour more than $250 billion annually into AI infrastructure, a sum exceeding the GDP of many nations, they desperately need a market large enough to justify these investments. Health care, representing one-fifth of the US economy, has emerged as its primary target. The result is a dangerous convergence: medicine’s evidence-based traditions colliding with venture capital’s growth-at-all-costs mentality.